Intravenous alendronate formulations

Details Intravenous alendronate formulations Intravenous alendronate formulations

A - Human Necessities

61

K

A61K 31/663 (2006.01) A61K 47/12 (2006.01) A61P 19/08 (2006.01)

Patent

CA 2197210

Disclosed is a therapy protocol for treating patients having metastatic bone disease, hypercalcemia of malignancy and/or metabolic bone disease by administering an intravenous, citrate-buffered formulation of alendronate which is isotonic with human blood.

La présente invention concerne un protocole thérapeutique de traitement de patients souffrant d'affections osseuses métastatiques ou d'hypercalcémies induites par une affection osseuse d'origine maligne et/ou métabolique, par administration d'une formulation intraveineuse d'alendronate tamponnée au citrate, cette formulation et le sang humain étant isotoniques.

Affiliated with

Also associated with

Rating

Intravenous alendronate formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intravenous alendronate formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous alendronate formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1663185